GE Healthcare Holds Annual Stockholders Meeting

An update from GE Healthcare Technologies Inc ( (GEHC) ) is now available.

On May 28, 2025, GE Healthcare Technologies Inc. held its annual stockholders meeting where 10 directors were elected for a one-year term. Stockholders also approved executive compensation and ratified Deloitte & Touche LLP as the independent auditor for 2025, while a proposal on termination pay arrangements was not approved.

The most recent analyst rating on (GEHC) stock is a Buy with a $100.00 price target. To see the full list of analyst forecasts on GE Healthcare Technologies Inc stock, see the GEHC Stock Forecast page.

Spark’s Take on GEHC Stock

According to Spark, TipRanks’ AI Analyst, GEHC is a Outperform.

GE Healthcare Technologies Inc shows solid financial performance and reasonable technical indicators, which are the primary factors contributing to the stock’s overall score. While the company faces tariff-related challenges impacting profitability and cash flow, effective mitigation efforts and strong product demand support a positive outlook.

To see Spark’s full report on GEHC stock, click here.

More about GE Healthcare Technologies Inc

GE Healthcare Technologies Inc. operates in the healthcare industry, focusing on providing medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. The company aims to enhance patient care and improve healthcare outcomes through its innovative solutions.

Average Trading Volume: 4,988,467

Technical Sentiment Signal: Strong Sell

Current Market Cap: $32.75B

See more insights into GEHC stock on TipRanks’ Stock Analysis page.